JP4312832B2 - インビボ組換え - Google Patents

インビボ組換え Download PDF

Info

Publication number: JP4312832B2
Authority: JP; Japan
Prior art keywords: dna; cell; homologous; replication; origin
Prior art date: 1996-12-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

JP52825198A

Other languages

English (en)

Japanese (ja)

Other versions

JP2002515755A (ja

JP2002515755A5 (de

Inventor

エスケルンビヨルンバッズ，マッズ

ドルベルウラスムッセン，ミカエル

リノヨルゲンセン，ペル

ベデルボルケルト，トルベン

ドゥスコエールリッヒ，スタニアラス

Original Assignee

ノボザイムスアクティーゼルスカブ

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-20

Filing date

1997-12-15

Publication date

2009-08-12

1997-12-15 Application filed by ノボザイムスアクティーゼルスカブ filed Critical ノボザイムスアクティーゼルスカブ

1997-12-15 Priority claimed from PCT/DK1997/000567 external-priority patent/WO1998028416A1/en

2002-05-28 Publication of JP2002515755A publication Critical patent/JP2002515755A/ja

2005-08-11 Publication of JP2002515755A5 publication Critical patent/JP2002515755A5/ja

2009-08-12 Application granted granted Critical

2009-08-12 Publication of JP4312832B2 publication Critical patent/JP4312832B2/ja

2017-12-15 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

230000006798 recombination Effects 0.000 title claims description 66
238000005215 recombination Methods 0.000 title claims description 66
238000001727 in vivo Methods 0.000 title claims description 47
108020004414 DNA Proteins 0.000 claims description 178
108091028043 Nucleic acid sequence Proteins 0.000 claims description 103
238000000034 method Methods 0.000 claims description 103
210000004027 cell Anatomy 0.000 claims description 100
108090000623 proteins and genes Proteins 0.000 claims description 81
239000013598 vector Substances 0.000 claims description 70
230000010076 replication Effects 0.000 claims description 51
239000005090 green fluorescent protein Substances 0.000 claims description 33
239000003550 marker Substances 0.000 claims description 33
108010043121 Green Fluorescent Proteins Proteins 0.000 claims description 28
102000004144 Green Fluorescent Proteins Human genes 0.000 claims description 27
102000004196 processed proteins & peptides Human genes 0.000 claims description 24
108090000765 processed proteins & peptides Proteins 0.000 claims description 24
102000004190 Enzymes Human genes 0.000 claims description 23
108090000790 Enzymes Proteins 0.000 claims description 23
229940088598 enzyme Drugs 0.000 claims description 23
229920001184 polypeptide Polymers 0.000 claims description 23
235000014469 Bacillus subtilis Nutrition 0.000 claims description 19
230000015572 biosynthetic process Effects 0.000 claims description 15
239000013604 expression vector Substances 0.000 claims description 14
238000012216 screening Methods 0.000 claims description 13
241000193830 Bacillus <bacterium> Species 0.000 claims description 11
244000063299 Bacillus subtilis Species 0.000 claims description 11
108020004511 Recombinant DNA Proteins 0.000 claims description 11
102000004169 proteins and genes Human genes 0.000 claims description 11
230000010354 integration Effects 0.000 claims description 10
102000007056 Recombinant Fusion Proteins Human genes 0.000 claims description 9
108010008281 Recombinant Fusion Proteins Proteins 0.000 claims description 9
230000004071 biological effect Effects 0.000 claims description 9
230000003115 biocidal effect Effects 0.000 claims description 8
210000000349 chromosome Anatomy 0.000 claims description 8
230000008569 process Effects 0.000 claims description 8
239000003242 anti bacterial agent Substances 0.000 claims description 6
241000588724 Escherichia coli Species 0.000 claims description 5
108091005804 Peptidases Proteins 0.000 claims description 4
239000004365 Protease Substances 0.000 claims description 4
230000033607 mismatch repair Effects 0.000 claims description 4
108090001060 Lipase Proteins 0.000 claims description 3
102000004882 Lipase Human genes 0.000 claims description 3
239000004367 Lipase Substances 0.000 claims description 3
230000002950 deficient Effects 0.000 claims description 3
230000000694 effects Effects 0.000 claims description 3
235000019421 lipase Nutrition 0.000 claims description 3
108010011619 6-Phytase Proteins 0.000 claims description 2
102000013142 Amylases Human genes 0.000 claims description 2
108010065511 Amylases Proteins 0.000 claims description 2
102000004316 Oxidoreductases Human genes 0.000 claims description 2
108090000854 Oxidoreductases Proteins 0.000 claims description 2
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 2
235000019418 amylase Nutrition 0.000 claims description 2
230000001580 bacterial effect Effects 0.000 claims description 2
108010005400 cutinase Proteins 0.000 claims description 2
102000034287 fluorescent proteins Human genes 0.000 claims description 2
108091006047 fluorescent proteins Proteins 0.000 claims description 2
-1 for example Proteins 0.000 claims description 2
230000001105 regulatory effect Effects 0.000 claims 2
230000003362 replicative effect Effects 0.000 claims 2
239000004382 Amylase Substances 0.000 claims 1
108010059892 Cellulase Proteins 0.000 claims 1
241000588722 Escherichia Species 0.000 claims 1
241000191940 Staphylococcus Species 0.000 claims 1
241000194017 Streptococcus Species 0.000 claims 1
210000003578 bacterial chromosome Anatomy 0.000 claims 1
229940106157 cellulase Drugs 0.000 claims 1
230000002255 enzymatic effect Effects 0.000 claims 1
210000005256 gram-negative cell Anatomy 0.000 claims 1
210000005255 gram-positive cell Anatomy 0.000 claims 1
230000004048 modification Effects 0.000 claims 1
238000012986 modification Methods 0.000 claims 1
229940085127 phytase Drugs 0.000 claims 1
239000013612 plasmid Substances 0.000 description 75
ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 40
229960003276 erythromycin Drugs 0.000 description 21
239000012634 fragment Substances 0.000 description 18
239000000499 gel Substances 0.000 description 9
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 8
229960005091 chloramphenicol Drugs 0.000 description 8
WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 8
230000014509 gene expression Effects 0.000 description 8
238000011534 incubation Methods 0.000 description 8
238000013518 transcription Methods 0.000 description 8
230000035897 transcription Effects 0.000 description 8
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 7
230000006801 homologous recombination Effects 0.000 description 7
238000002744 homologous recombination Methods 0.000 description 7
239000011543 agarose gel Substances 0.000 description 6
230000008901 benefit Effects 0.000 description 6
238000000746 purification Methods 0.000 description 6
230000009466 transformation Effects 0.000 description 6
102000053602 DNA Human genes 0.000 description 5
238000012408 PCR amplification Methods 0.000 description 5
238000012258 culturing Methods 0.000 description 5
238000001962 electrophoresis Methods 0.000 description 5
101150079601 recA gene Proteins 0.000 description 5
229920001817 Agar Polymers 0.000 description 4
108010010803 Gelatin Proteins 0.000 description 4
239000006142 Luria-Bertani Agar Substances 0.000 description 4
108020005091 Replication Origin Proteins 0.000 description 4
239000008272 agar Substances 0.000 description 4
108090000637 alpha-Amylases Proteins 0.000 description 4
238000000137 annealing Methods 0.000 description 4
239000000872 buffer Substances 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
238000010367 cloning Methods 0.000 description 4
238000010276 construction Methods 0.000 description 4
238000004925 denaturation Methods 0.000 description 4
230000036425 denaturation Effects 0.000 description 4
239000008273 gelatin Substances 0.000 description 4
229920000159 gelatin Polymers 0.000 description 4
235000019322 gelatine Nutrition 0.000 description 4
235000011852 gelatine desserts Nutrition 0.000 description 4
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
229910001629 magnesium chloride Inorganic materials 0.000 description 4
238000012360 testing method Methods 0.000 description 4
238000011144 upstream manufacturing Methods 0.000 description 4
101150066002 GFP gene Proteins 0.000 description 3
108090000787 Subtilisin Proteins 0.000 description 3
238000012217 deletion Methods 0.000 description 3
230000037430 deletion Effects 0.000 description 3
239000003599 detergent Substances 0.000 description 3
238000001943 fluorescence-activated cell sorting Methods 0.000 description 3
238000009396 hybridization Methods 0.000 description 3
238000010348 incorporation Methods 0.000 description 3
239000002609 medium Substances 0.000 description 3
108010020132 microbial serine proteinases Proteins 0.000 description 3
239000000203 mixture Substances 0.000 description 3
238000010561 standard procedure Methods 0.000 description 3
OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 2
229920000936 Agarose Polymers 0.000 description 2
241000194108 Bacillus licheniformis Species 0.000 description 2
239000012623 DNA damaging agent Substances 0.000 description 2
241000192125 Firmicutes Species 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
102000004877 Insulin Human genes 0.000 description 2
108090001061 Insulin Proteins 0.000 description 2
108700026244 Open Reading Frames Proteins 0.000 description 2
102000035195 Peptidases Human genes 0.000 description 2
238000012181 QIAquick gel extraction kit Methods 0.000 description 2
102000004139 alpha-Amylases Human genes 0.000 description 2
229940024171 alpha-amylase Drugs 0.000 description 2
229940088710 antibiotic agent Drugs 0.000 description 2
238000004851 dishwashing Methods 0.000 description 2
239000008103 glucose Substances 0.000 description 2
239000003630 growth substance Substances 0.000 description 2
229940088597 hormone Drugs 0.000 description 2
239000005556 hormone Substances 0.000 description 2
238000012623 in vivo measurement Methods 0.000 description 2
230000000977 initiatory effect Effects 0.000 description 2
229940125396 insulin Drugs 0.000 description 2
229960000318 kanamycin Drugs 0.000 description 2
229930027917 kanamycin Natural products 0.000 description 2
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
229930182823 kanamycin A Natural products 0.000 description 2
238000009630 liquid culture Methods 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
108020004707 nucleic acids Proteins 0.000 description 2
102000039446 nucleic acids Human genes 0.000 description 2
150000007523 nucleic acids Chemical class 0.000 description 2
239000002773 nucleotide Substances 0.000 description 2
125000003729 nucleotide group Chemical group 0.000 description 2
101150096833 repF gene Proteins 0.000 description 2
108091008146 restriction endonucleases Proteins 0.000 description 2
238000007423 screening assay Methods 0.000 description 2
239000000126 substance Substances 0.000 description 2
230000004083 survival effect Effects 0.000 description 2
238000001890 transfection Methods 0.000 description 2
LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
DJHGAFSJWGLOIV-UHFFFAOYSA-K Arsenate3- Chemical compound [O-][As]([O-])([O-])=O DJHGAFSJWGLOIV-UHFFFAOYSA-K 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
102000005575 Cellulases Human genes 0.000 description 1
108010084185 Cellulases Proteins 0.000 description 1
108020004638 Circular DNA Proteins 0.000 description 1
238000012270 DNA recombination Methods 0.000 description 1
102100036263 Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial Human genes 0.000 description 1
102000018997 Growth Hormone Human genes 0.000 description 1
108010051696 Growth Hormone Proteins 0.000 description 1
108091027305 Heteroduplex Proteins 0.000 description 1
101001001786 Homo sapiens Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial Proteins 0.000 description 1
102000002265 Human Growth Hormone Human genes 0.000 description 1
108010000521 Human Growth Hormone Proteins 0.000 description 1
102000003960 Ligases Human genes 0.000 description 1
108090000364 Ligases Proteins 0.000 description 1
239000006137 Luria-Bertani broth Substances 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
108020005187 Oligonucleotide Probes Proteins 0.000 description 1
230000027151 SOS response Effects 0.000 description 1
BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
241000191967 Staphylococcus aureus Species 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
239000007984 Tris EDTA buffer Substances 0.000 description 1
241000700605 Viruses Species 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000004913 activation Effects 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
229940025131 amylases Drugs 0.000 description 1
229910052787 antimony Inorganic materials 0.000 description 1
WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
229940000489 arsenate Drugs 0.000 description 1
101150036080 at gene Proteins 0.000 description 1
238000010170 biological method Methods 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
238000012219 cassette mutagenesis Methods 0.000 description 1
230000003915 cell function Effects 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
238000004590 computer program Methods 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
230000001351 cycling effect Effects 0.000 description 1
230000007547 defect Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000009795 derivation Methods 0.000 description 1
230000029087 digestion Effects 0.000 description 1
238000004520 electroporation Methods 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
230000006862 enzymatic digestion Effects 0.000 description 1
238000001976 enzyme digestion Methods 0.000 description 1
230000006870 function Effects 0.000 description 1
230000004927 fusion Effects 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
229910001385 heavy metal Inorganic materials 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
230000000415 inactivating effect Effects 0.000 description 1
230000006698 induction Effects 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
238000011031 large-scale manufacturing process Methods 0.000 description 1
239000007788 liquid Substances 0.000 description 1
230000001320 lysogenic effect Effects 0.000 description 1
239000000463 material Substances 0.000 description 1
238000000691 measurement method Methods 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
238000002703 mutagenesis Methods 0.000 description 1
231100000350 mutagenesis Toxicity 0.000 description 1
239000002751 oligonucleotide probe Substances 0.000 description 1
230000002018 overexpression Effects 0.000 description 1
238000013492 plasmid preparation Methods 0.000 description 1
238000007747 plating Methods 0.000 description 1
108091033319 polynucleotide Proteins 0.000 description 1
102000040430 polynucleotide Human genes 0.000 description 1
239000002157 polynucleotide Substances 0.000 description 1
229910000160 potassium phosphate Inorganic materials 0.000 description 1
235000011009 potassium phosphates Nutrition 0.000 description 1
230000002062 proliferating effect Effects 0.000 description 1
210000001938 protoplast Anatomy 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
238000011069 regeneration method Methods 0.000 description 1
238000011160 research Methods 0.000 description 1
239000000523 sample Substances 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
230000037432 silent mutation Effects 0.000 description 1
235000020183 skimmed milk Nutrition 0.000 description 1
238000002791 soaking Methods 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000000243 solution Substances 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
230000002103 transcriptional effect Effects 0.000 description 1
238000010361 transduction Methods 0.000 description 1
230000026683 transduction Effects 0.000 description 1
238000000844 transformation Methods 0.000 description 1

Images

Landscapes

Micro-Organisms Or Cultivation Processes Thereof (AREA)
Enzymes And Modification Thereof (AREA)

JP52825198A 1996-12-20 1997-12-15 インビボ組換え Expired - Fee Related JP4312832B2 (ja)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
DK147196		1996-12-20
DK59297		1997-05-23
DK93597		1997-08-14
DK0592/97		1997-08-14
DK0935/97		1997-08-14
DK1471/96		1997-08-14
PCT/DK1997/000567 WO1998028416A1 (en)	1996-12-20	1997-12-15	In vivo recombination

Publications (3)

Publication Number	Publication Date
JP2002515755A JP2002515755A (ja)	2002-05-28
JP2002515755A5 JP2002515755A5 (de)	2005-08-11
JP4312832B2 true JP4312832B2 (ja)	2009-08-12

Family

ID=27220804

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP52825198A Expired - Fee Related JP4312832B2 (ja)	1996-12-20	1997-12-15	インビボ組換え

Country Status (4)

Country	Link
JP (1)	JP4312832B2 (de)
AT (1)	ATE284958T1 (de)
AU (1)	AU7873698A (de)
DE (1)	DE69731970T2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN114214354A (zh) *	2021-12-31	2022-03-22	天津科技大学	一种双载体表达体系及其构建方法与应用

1997
- 1997-12-15 AU AU78736/98A patent/AU7873698A/en not_active Abandoned
- 1997-12-15 AT AT97948747T patent/ATE284958T1/de not_active IP Right Cessation
- 1997-12-15 JP JP52825198A patent/JP4312832B2/ja not_active Expired - Fee Related
- 1997-12-15 DE DE69731970T patent/DE69731970T2/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
ATE284958T1 (de)	2005-01-15
DE69731970T2 (de)	2005-12-29
DE69731970D1 (de)	2005-01-20
AU7873698A (en)	1998-07-17
JP2002515755A (ja)	2002-05-28

Legal Events

Date	Code	Title	Description
2005-01-06	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20041209
2005-01-06	A621	Written request for application examination	Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20041209
2005-01-06	RD04	Notification of resignation of power of attorney	Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20041209
2008-08-26	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080826
2008-12-04	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20081117
2008-12-22	A602	Written permission of extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20081222
2009-03-19	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090226
2009-04-03	TRDD	Decision of grant or rejection written
2009-04-14	A01	Written decision to grant a patent or to grant a registration (utility model)	Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090414
2009-04-16	A01	Written decision to grant a patent or to grant a registration (utility model)	Free format text: JAPANESE INTERMEDIATE CODE: A01
2009-05-21	A61	First payment of annual fees (during grant procedure)	Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090514
2009-05-22	FPAY	Renewal fee payment (event date is renewal date of database)	Free format text: PAYMENT UNTIL: 20120522 Year of fee payment: 3
2009-05-22	R150	Certificate of patent or registration of utility model	Free format text: JAPANESE INTERMEDIATE CODE: R150
2012-04-26	FPAY	Renewal fee payment (event date is renewal date of database)	Free format text: PAYMENT UNTIL: 20120522 Year of fee payment: 3
2012-05-08	FPAY	Renewal fee payment (event date is renewal date of database)	Free format text: PAYMENT UNTIL: 20130522 Year of fee payment: 4
2013-05-22	LAPS	Cancellation because of no payment of annual fees

Publication	Publication Date	Title
EP0948615B1 (de)	2004-12-15	In vivo rekombination
Vary et al.	2007	Bacillus megaterium—from simple soil bacterium to industrial protein production host
Minton	1995	Molecular genetics of clostridial neurotoxins
US5882888A (en)	1999-03-16	DNA integration by transposition
JP4571304B2 (ja)	2010-10-27	バチルス細胞内でのポリペプチドの製法
CA2152371C (en)	2008-12-02	Dna amplification
JPH01502398A (ja)	1989-08-24	原核微生物の染色体ｄｎａにおける安定した遺伝子増幅
JP2001514529A (ja)	2001-09-11	プロテアーゼ活性を有するポリペプチドをコードする核酸
JPH04507346A (ja)	1992-12-24	アルカリ性タンパク質分解酵素およびその製造方法
EP3532619A1 (de)	2019-09-04	Flp-vermittelte genomische integration
JP2016507252A (ja)	2016-03-10	定方向進化のためのライブラリーの作製方法
JP2001503641A (ja)	2001-03-21	バシラス細胞のサーファクチン突然変異株におけるポリペプチドの製造方法
CN103154263A (zh)	2013-06-12	诱导的孢子形成筛选方法
Long‐McGie et al.	2000	Rapid in vivo evolution of a β‐lactamase using phagemids
JP4312832B2 (ja)	2009-08-12	インビボ組換え
WO2022129166A1 (en)	2022-06-23	Mutated host cells with reduced cell motility
JP2008504832A (ja)	2008-02-21	バクテリオファージにおける組換え遺伝子の産生
US6291165B1 (en)	2001-09-18	Shuffling of heterologous DNA sequences
CN114630895A (zh)	2022-06-14	用于增加地衣芽孢杆菌中蛋白质生产的组合物和方法
CN101384615A (zh)	2009-03-11	形成或分解聚氨基酸的地衣芽胞杆菌新基因产物以及据此改进的生物技术生产方法
US7858762B2 (en)	2010-12-28	Phosphate limited inducible promoter and a Bacillus expression system
US9416359B2 (en)	2016-08-16	Method for constructing mutagenesis libraries in situ
JPH11514527A (ja)	1999-12-14	バキルスエスピー（Ｂａｃｉｌｌｕｓｓｐ．）用の陽性選択ベクター
JP2002508669A (ja)	2002-03-19	所望の遺伝子の複数コピー、及び選択マーカーではなく、スクリーニング可能マーカーを含むタンパク質産生細胞
CN1946844B (zh)	2012-02-29	通过利用两个染色体外元件在原核细胞中产生重组基因